| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 691819 | Null | 3.88440367201721e-005 | 0.45331703 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 3.88440367201721e-005 | 0.39984976 |
| NSC 664404 | - | 4.88335076207314e-005 | 0.69925812 |
| NSC 693634 | Null | 4.88335076207314e-005 | 0.24808746 |
| NSC 736793 | Null | 4.88335076207314e-005 | 0.45816819 |
| NSC 673181 | Null | 4.9327988091187e-006 | 0.32572942 |
| NSC 743528 | Null | 4.9327988091187e-006 | 0.40058927 |
| NSC 634035 | 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one | 6.70485325419768e-005 | 0.32777655 |
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 6.70485325419768e-005 | 0.35971344 |
| NSC 724781 | (1S,4R,5R,8R,12R,13S)-9-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl -10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1. 04,13.08,13]hexadec-9-en-9-yl]methoxy}-2-butenyl)oxy]methyl} -1,5-dimethyl-10 | 8.45012998844858e-005 | 0.28468586 |